Braveheart Resources Inc. announce the following changes to the Board effective this date. Peter A. Lacey, ICD.D has agreed to join the Board as an Independent Director of the Company. Brian Murray, one of the co-founders of Braveheart and its longest standing Director has notified the Company of his intention to retire. Mr. Lacey is currently Chairman of Hemostemix Inc., a startup stem cell public company (TSXV: HEM) which has 91 global patents and is completing Phase 2 clinical trial for FDA approval.